Edgestream Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Buy |
+6,344
| New | +$526K | 0.01% | 724 |
|
|
2024
Q4 | – | Sell |
-13,171
| Closed | -$1.3M | – | 1128 |
|
|
2024
Q3 | $1.3M | Buy |
13,171
+3,103
| +31% | +$307K | 0.06% | 516 |
|
|
2024
Q2 | $933K | Buy |
10,068
+6,528
| +184% | +$605K | 0.04% | 540 |
|
|
2024
Q1 | $336K | Buy |
+3,540
| New | +$336K | 0.02% | 697 |
|
|
2023
Q4 | – | Sell |
-29,030
| Closed | -$2.12M | – | 1104 |
|
|
2023
Q3 | $2.12M | Buy |
29,030
+21,081
| +265% | +$1.54M | 0.17% | 179 |
|
|
2023
Q2 | $661K | Buy |
7,949
+132
| +2% | +$11K | 0.06% | 467 |
|
|
2023
Q1 | $596K | Buy |
+7,817
| New | +$596K | 0.07% | 376 |
|